Cardiology

POWERING ADVANCEMENTS IN HEART HEALTH
The ability to detect cardiac biomarkers at ultra-low levels is advancing the future of heart health.

Simoa assays have the potential to detect cardiac biomarkers, which are instrumental for predicting major adverse cardiovascular events, development of heart failure or transition to end-stage kidney disease, earlier than ever before. Further, the ability to detect minute changes in these biomarkers could enable the identification of at-risk patients earlier in their disease progression to guide more personalized, preventive care.

CARDIOLOGY ASSAYS

Available for Scientific Research

IL-15	IL-17A	IL-17A (mouse)	IL-1β	IL-6
IL-6 (mouse)	NT-proBNP	TGFβ	TNFα	TNFα (mouse)
Troponin-IVEGF	Tau

Go Top

At CBT, we use only internationally recognized gold standard DNA sequencing and microarray technology to produce the most accurate results. With collaboration from the United States and Russian clinical gene therapy and data analysis centers, along with the University of Hong Kong, Chinese Academy of Sciences and Tongji University, we have the finest team of experts and consultants to provide world-leading genetic testing services. In addition to our expert team, a completely automated data analysis and reporting system produce fast and reliable results to provide premium services to our customers.